13FPulse
中
CD

CDRE CADRE HOLDINGS INC

2026Q2 · CUSIP 12763L105 · Sector: Healthcare & Biotech

Normal

Fund flows are within the usual range

Funds that own it
153
Institutions that reported holding it to the SEC
Net decrease in holders
13
Last quarter 166 → now 153
How unusual is that
Bottom 20%
Stronger than only 11% of US stocks
What the filings say, in one paragraph

153 funds held CDRE at the end of 2026Q2, down 13 from the quarter before. Fund flows are within the usual range — nothing unusual. On the business itself, revenue over the last 12 months was $686M(YoY +19.7%), the P/E is 35.8x, return on equity is 10.4%. CDRE has had 3 buying rushes in its history, and the price moved +4.1% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2022Q1: holders=47 2022Q2: holders=71 2022Q3: holders=71 2022Q4: holders=77 2023Q1: holders=78 2023Q2: holders=72 2023Q3: holders=80 2023Q4: holders=102 2024Q1: holders=140 2024Q2: holders=129 2024Q3: holders=126 2024Q4: holders=142 2025Q1: holders=157 2025Q2: holders=162 2025Q3: holders=144 2025Q4: holders=161 2026Q1: holders=166 2026Q2: holders=153 -38 -19 +0 +19 +38 42109175 22Q122Q323Q123Q324Q124Q325Q125Q326Q126Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 3 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2025Q1 Top 20% -16.7% +19.4%
2024Q1 Top 10% +15.7% +7.3%
2022Q2 Top 5% -7.1% -14.4%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
103
Change in large funds
+3
Total value they hold
$932M
Funds buying for the first time
19
Funds that sold out entirely
32
Price change that quarter
-1.9%
Funds holding puts (bearish)
1
Funds holding calls (bullish)
0

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
35.8
EPS (TTM)
$0.80
EPS YoY
-14.9%
Revenue (TTM)
$0.7B
Revenue YoY
+19.7%
Net margin
5.3%
ROE
10.4%
Debt ratio
62.2%
FCF (TTM)
$78M
Dividend (TTM)
$0.39
Quarterly Revenue & EPS
2021-09-30: EPS -0.19 2021-12-31: EPS 0.13 2022-03-31: EPS -0.30 2022-06-30: EPS 0.12 2022-09-30: EPS 0.13 2022-12-31: EPS 0.21 2023-03-31: EPS 0.19 2023-06-30: EPS 0.29 2023-09-30: EPS 0.29 2023-12-31: EPS 0.25 2024-03-31: EPS 0.18 2024-06-30: EPS 0.31 2024-09-30: EPS 0.09 2024-12-31: EPS 0.32 2025-03-31: EPS 0.23 2025-06-30: EPS 0.30 2025-09-30: EPS 0.27 2025-12-31: EPS 0.22 2026-03-31: EPS 0.05 2026-06-30: EPS 0.26 0M 104M 207M $M -0.33 0.01 0.35 202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 37 26 178 329 20222023202420252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-6M9M24M 2020202120222023202420252026
Latest quarter $20M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.